Skip to content
GRIGRI Bio, Inc.

Earnings

When GRI Bio, Inc. reports, what it reported each quarter, and how the stock took the results.

27 quarters. Mar 31, 2020 to Sep 30, 2026. USD.

Next results · Q4 2026Projected

10-K due Feb 11 – Apr 1

No earnings release is on file for this company, so the day is the 10-K’s, projected from its last 6 filings.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Feb 11 – Apr 1

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
—
Revenue, change from a year earlier: Q1 2022 n/m, Q4 2021 n/m, Q3 2021 n/m, Q2 2021 n/m
Net income
-$2.66M
Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m

Quarter by quarter

Q4 2023—

Latest results

  1. Q3 2026Nov 13, 2026, after the close
    Revenue
    —
    —
    Net income
    -$1.51M
    N/M
    EPS
    -$0.69
    N/M
  2. Q2 2026Aug 14, 2026, before the open5.6%by the close of Aug 14
    Revenue
    —
    —
    Net income
    -$1.64M
    N/M
    EPS
    -$0.91
    N/M
  3. Q1 2026May 13, 2026, after the close3.6%by the close of May 14
    Revenue
    —
    —
    Net income
    -$2.00M
    N/M
    EPS
    -$1.61
    N/M
  4. Q4 2025Jan 30, 2026, before the open1.8%by the close of Jan 30
    Revenue
    —
    —
    Net income
    -$2.66M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026—Nov 13, 202644 d10-Q——-$0.69—
Q2 2026Jun 30, 2026—Aug 14, 202645 d10-Q——-$0.915.6%
Q1 2026Mar 31, 2026—May 13, 202643 d10-Q——-$1.613.6%
FY 2025
Q4 2025derivedDec 31, 2025—Jan 30, 202630 d10-K———1.8%
Q3 2025Sep 30, 2025—Nov 14, 202545 d10-Q——-$35.885.0%
Q2 2025Jun 30, 2025—Aug 14, 202545 d10-Q——-$36.72+10.0%
Q1 2025Mar 31, 2025May 15, 2025 · pre-marketMay 15, 202545 d10-Q——-$162.304.1%
FY 2024
Q4 2024derivedDec 31, 2024—Mar 14, 202573 d10-K———+7.0%
Q3 2024Sep 30, 2024Nov 14, 2024 · after-hoursNov 14, 202445 d10-Q——-$11.4214.6%
Q2 2024Jun 30, 2024Aug 14, 2024 · pre-marketAug 14, 202445 d10-Q——-$61.85—
Q1 2024Mar 31, 2024Apr 1, 2024 · pre-marketMay 10, 202440 d10-Q——-$101.05—
Earlier years, FY 2020 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 13, 2026000070
10-QAug 14, 2026000055
10-QMay 13, 2026000044
10-KJan 30, 2026000033
10-QNov 14, 2025000151
10-QAug 14, 2025000106
10-QMay 15, 2025000073
10-KMar 14, 2025000050
10-QNov 14, 2024000151
10-QAug 14, 2024000105

Provenance

ProvenanceData status and checks

GRI Bio, Inc. · CIK 1824293 · Engraved from SEC EDGAR